Hoppa till innehåll
Pelago Bioscience Logotype for Pelago bioscience
  • Services
    • CETSA®
      • Unbiased Profiling
        • Proteome Wide
        • Selectivity Profiling
      • Targeted Profiling
  • Drug Discovery Phases
    • Target Discovery
      • Target Identification and Deconvolution
    • Lead Generation
      • Primary Screening
      • Hit Confirmation
      • Potency Ranking 
      • Selectivity Profiling
    • Lead Optimization
      • Potency Ranking 
      • Selectivity Profiling
      • Target Identification and Deconvolution
      • Mechanism of Action
      • Translational Studies
    • Preclinical Studies
      • Translational Studies
      • In Vivo Target Engagement
      • Biomarker Discovery
  • About CETSA®
    • Why CETSA?
    • Your key to biological relevance
  • Case Stories
  • About us
    • Our story
    • Our facilities
  • News & Events
  • Blog
  • Contact Us
    • Contact us
    • Career
    • Whistleblowing
  • Scientific Hub
  • Home
  • Scientific Hub
  • Brochures
  • Selectivity Profiling Brochure – Compound Data

Selectivity Profiling Brochure – Compound Data

compound data
compound data
Download here

cetsa mass spectrometry

Unbiased Selectivity Profiling: with CETSA® and Mass Spectrometry

Unbiased Selectivity Profiling: Revealing True Compound Specificity and Off-Target Interactions CETSA mass spectrometry profiling enables unbiased analysis of compound selectivity in drug discovery—he...

Read more about Unbiased Selectivity Profiling: with CETSA® and Mass Spectrometry
cdk4

Enhancing Primary Screening with CETSA: A Case Study in CDK4 Hit Identification 

Whether exploring challenging targets or optimizing your screening approach, this poster illustrates how CETSA can unlock new insights and help prioritize the right leads faster.  Download now to...

Read more about Enhancing Primary Screening with CETSA: A Case Study in CDK4 Hit Identification 
ms detection

Unbiased Selectivity Profiling, CETSA with MS detection 

Unbiased analysis of compound selectivity Selectivity in drug development is an essential prerequisite for the generation of lead candidates. The limited number of proteins profiled in traditional pan...

Read more about Unbiased Selectivity Profiling, CETSA with MS detection 
Cracking the Code of Mutant p53: A CETSA®-Powered Investigation at AACR 2025 pharmacology discovery services

Our Services – Pharmacology Discovery Services

Read more about Our Services – Pharmacology Discovery Services
See more
Logotype for Pelago bioscience

Pelago Bioscience AB
Scheeles väg 1
171 65 Solna
Sweden

  • About us
    • Our facilities
  • Drug Discovery Phases
    • Target Discovery
    • Lead Optimization
    • Lead Generation
    • Preclinical Studies
  • About CETSA®
    • Your key to biological relevance
  • News & Events
    • Contact Us
    • Whistleblowing
    • Login
Login
Subscribe to our newsletter

© 2026 Pelago Bioscience

Privacy policy
Let's discuss your project